Targeted Therapy in Pharmacology: Insights on Small Molecule Drugs and High Throughput Screening
Understanding Targeted Therapy in Drug Discovery
Targeted therapy is revolutionizing pharmacology by enabling the development of small molecule drugs through innovative high throughput screening techniques. The drug discovery process begins with target identification, where critical decisions on target validity are made.
Phases in Drug Discovery
- Hit Identification: The process of finding molecules that interact with the established target.
- Hit-to-Lead Optimization: A crucial phase where medicinal chemistry and pharmacokinetics work together to refine drug candidates.
Challenges and Innovations
The biggest challenges in drug discovery stem from our incomplete understanding of human biology and the difficulties in translating preclinical data to clinical outcomes. However, new technologies like artificial intelligence are enhancing our ability to prioritize candidates and optimize compounds, improving the success rates of drug discovery.
This evolving landscape is paving the way for faster, more efficient drug development processes, promising better therapeutic outcomes for patients.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.